Pathology/Lab Coding Alert

Drug Screens 2012:

G0434 Payment Won't Change, CMS Says

Agency denies reconsideration request.Your lab will continue to get the same pay for a dipstick or chemistry analyzer screening for multiple drug classes in a single patient encounter. That's according to the agency's preliminary payment determination, in which CMS denied industry commentators' requests at the annual laboratory public meeting to distinguish the services. Keep With Current PracticeWhen your lab performs a drug screen for a Medicare beneficiary, you should code the work as one unit of G0434 (Drug screen, other than chromatographic; any number of drug classes, by CLIA waived test or moderate complexity test, per patient encounter) when the lab uses any of the following methods:CLIA waived or non-instrumented moderate complexity test systems read by direct optical observation (such as dipsticks, cups, or cards)Moderate complexity instrumented test systems intended for repeated use, not read by direct optical observation (such as spectrophotometers, multi-channel chemistry analyzers, and fluorometers).Don't Expect Additional CodeSeveral [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

View All